Insider · CIK 0001219890
INGRAM ROBERT ALEXANDER
Reports to the SEC for 18 companies · IRVINE, CA
Transactions
50
Companies
18
Filings
18
CIK
0001219890
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-02-28 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$20K |
| 2022-12-16 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$14.1K |
| 2022-11-30 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$20K |
| 2022-09-16 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$17.3K |
| 2022-08-31 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$20K |
| 2022-06-17 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$17.3K |
| 2022-06-10 | BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-07 | BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award | — |
| 2022-06-07 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | — |
| 2022-05-31 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$19.3K |
| 2022-03-18 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$17.5K |
| 2022-02-28 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2021-12-17 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$17.5K |
| 2021-11-30 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2021-09-17 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$18.5K |
| 2021-08-31 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2021-06-18 | BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-18 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$16.3K |
| 2021-05-28 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2021-05-25 | BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award | — |
| 2021-03-18 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$16.3K |
| 2021-02-26 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2020-12-15 | BDTXBlack Diamond Therapeutics, Inc.A Award | +$17.3K |
| 2020-11-30 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2020-09-30 | BDTXBlack Diamond Therapeutics, Inc.P Purchase | +$152K |
| 2020-09-25 | BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-08-31 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2020-07-28 | NVN Liquidation, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-06-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2020-05-12 | BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award | — |
| 2020-03-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.8K |
| 2019-12-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2019-11-18 | BCRXBIOCRYST PHARMACEUTICALS INCP Purchase | +$29K |
| 2019-09-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2019-07-31 | NVN Liquidation, Inc.Stock Option (Right to Buy)A Award | — |
| 2019-05-29 | BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award | — |
| 2019-05-22 | NVN Liquidation, Inc.P Purchase | +$111K |
| 2018-10-17 | WOLFWOLFSPEED, INC.A Award | +$30K |
| 2018-09-28 | NVN Liquidation, Inc.P Purchase | +$142K |
| 2018-08-30 | WOLFWOLFSPEED, INC.M Exercise/Conversion | +$124K |
| 2018-08-30 | WOLFWOLFSPEED, INC. · NONQUALIFIED STOCK OPTION (RIGHT TO BUY)M Exercise/Conversion | −$124K |
| 2018-08-15 | WOLFWOLFSPEED, INC.A Award | +$30K |
| 2018-06-20 | BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award | — |
| 2018-06-04 | NVN Liquidation, Inc.Stock Option (Right to Buy)A Award | — |
| 2018-06-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2018-04-25 | WOLFWOLFSPEED, INC.A Award | +$30K |
| 2018-03-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2018-01-24 | WOLFWOLFSPEED, INC.A Award | +$30K |
| 2017-12-01 | BCRXBIOCRYST PHARMACEUTICALS INCA Award | +$18.7K |
| 2017-10-18 | WOLFWOLFSPEED, INC.A Award | +$25K |
Recent filings
- 4INGRAM ROBERT ALEXANDER0001127602-23-008391SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-22-012795SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-22-026823SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-22-009771SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-22-022009SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-22-006739SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-22-006518SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-22-017165SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-22-016390SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-22-003184SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-22-007725SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-21-006070SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-21-030043SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001415889-21-004540SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-21-024776SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001104659-21-084242SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-21-018501SEC(opens sec.gov)
- 4INGRAM ROBERT ALEXANDER0001127602-21-018181SEC(opens sec.gov)
Companies
- ALLERGAN INCDirector
- Bausch Health Companies Inc.DirectorBHC
- BIOCRYST PHARMACEUTICALS INCDirectorBCRX
- Black Diamond Therapeutics, Inc.FORMER DIRECTORBDTX
- Clearside Biomedical, Inc.10% Owner, May be part of a 13(d) GroupCLSDQ
- Edwards Lifesciences CorpDirectorEW
- G1 Therapeutics, Inc.10% Owner
- LOWES COMPANIES INCDirectorLOW
- NORTEL NETWORKS CORPDirector
- NVN Liquidation, Inc.Director
- OSI PHARMACEUTICALS INCDirector
- PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCDirector
- PhaseBio Pharmaceuticals Inc10% Owner
- QUINTILES TRANSNATIONAL CORPDirector
- REGENERON PHARMACEUTICALS, INC.DirectorREGN
- VALEANT PHARMACEUTICALS INTERNATIONALDirector
- WACHOVIA CORP NEWDirector
- WOLFSPEED, INC.DirectorWOLF
Address
2525 DUPONT DRIVE
IRVINE, CA, 92612